<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7048954/results/search/test_trace/results.xml">
  <result pre="table-count: ref-count: page-count: Introduction Chronic hepatitis C virus, (HCV, Hepacivirus)" exact="infection" post="is a serious health issue worldwide. In spite of"/>
  <result pre="health issue worldwide. In spite of potent antiviral agents, chronic" exact="infection" post="can still lead to decompensated cirrhosis and hepatocellular carcinoma"/>
  <result pre="fever, West Nile and Zika.3 These pathogens still present formidable" exact="treatment" post="challenges. The HCV NS3-4A protease-helicase is an attractive viral"/>
  <result pre="with conventional pegylated interferon and ribavirin therapies and significantly improved" exact="treatment" post="outcomes.5–7 Second generation protease inhibitors were subsequently shown to"/>
  <result pre="activity, yet they still have issues with viral resistance and" exact="treatment" post="versatility.11–17 Iron protoporphyrin (heme) and structurally related metalloprotoporphyrins (MPP)"/>
  <result pre="were performed as previously described using enhanced chemiluminescence for signal" exact="detection" post="(ECLTM, Amersham).29 Statistical Determinations All mean FRET values were"/>
  <result pre="3–4 replicates per point. A completely randomized design with multiple" exact="treatment" post="groups was used for the analysis of variance for"/>
  <result pre="either pairwise using Fisher’s Least Significant Difference test or among" exact="treatment" post="groups using F statistic. All experiments were repeated at"/>
  <result pre="= 1.83. (C). Western Blots for HCV proteins after HCV" exact="infection" post="of Huh 7.5 or Huh 5.15NS replicon cells. Log-phase,"/>
  <result pre="and boceprevir. Additionally, mutations at position 156 also arise after" exact="treatment" post="with next-generation anti-proteases such as simeprevir and grazoprevir.35 Enzyme"/>
  <result pre="of a specific anti-dengue drug although antiviral therapy in acute" exact="infection" post="may reduce the risk for severe DENV.45 However, Tseng"/>
  <result pre="our group reported for HCV NS3-4A.23,25 Furthermore, biliverdin or CoPP" exact="treatment" post="of infected DENV cells restored innate type I interferon"/>
  <result pre="the use of the linear peptidomimetic compounds, A156T arises during" exact="treatment" post="with nearly all linear and macrocyclic compounds developed to"/>
  <result pre="work. References References 1.TholeyDM, AhnJ. Impact of hepatitis C virus" exact="infection" post="on hepatocellular carcinoma. Gastroenterol Clin North Am. 2015;44(4):761–773. doi:10.1016/j.gtc.2015.07.00526600218"/>
  <result pre="2011;364(13):1195–1206. doi:10.1056/NEJMoa101049421449783 7.ShermanKE, FlammSL, AfdhalNH, et al. Response-guided telaprevir combination" exact="treatment" post="for hepatitis C virus infection. N Engl J Med."/>
  <result pre="PoordadF, WangS, et al. High efficacy of ABT-493 and ABT-530" exact="treatment" post="in patients with HCV genotype 1 or 3 infection"/>
  <result pre="ABT-530 treatment in patients with HCV genotype 1 or 3" exact="infection" post="and compensated cirrhosis. Gastroenterology. 2016;151(4):651–659.e651. doi:10.1053/j.gastro.2016.07.02027456384 14.JacobsonIM, LawitzE, GaneEJ,"/>
  <result pre="Efficacy and safety of 12 weeks versus 18 weeks of" exact="treatment" post="with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without"/>
  <result pre="with or without ribavirin for hepatitis C virus genotype 1" exact="infection" post="in previously untreated patients with cirrhosis and patients with"/>
  <result pre="Efficacy and safety of 8 weeks versus 12 weeks of" exact="treatment" post="with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without"/>
  <result pre="et al. Down-regulation of heme oxygenase-1 by hepatitis C virus" exact="infection" post="in vivo and by the in vitro expression of"/>
 </snippets>
</snippetsTree>
